Sabra Health Care REIT Statistics
Total Valuation
SBRA has a market cap or net worth of $4.01 billion. The enterprise value is $6.36 billion.
Important Dates
The last earnings date was Wednesday, February 19, 2025, after market close.
| Earnings Date | Feb 19, 2025 |
| Ex-Dividend Date | Feb 14, 2025 |
Share Statistics
SBRA has 237.91 million shares outstanding. The number of shares has increased by 1.40% in one year.
| Current Share Class | 237.91M |
| Shares Outstanding | 237.91M |
| Shares Change (YoY) | +1.40% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 97.06% |
| Float | 234.10M |
Valuation Ratios
The trailing PE ratio is 31.22 and the forward PE ratio is 23.94. SBRA's PEG ratio is 0.51.
| Price/FFO Ratio | 12.40 |
| Price/AFFO Ratio | n/a |
| PE Ratio | 31.22 |
| Forward PE | 23.94 |
| PS Ratio | 5.60 |
| Forward PS | 5.34 |
| PB Ratio | 1.46 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | 12.92 |
| P/OCF Ratio | 12.92 |
| PEG Ratio | 0.51 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 15.09, with an EV/FCF ratio of 20.46.
| EV / Earnings | 50.15 |
| EV / Sales | 9.04 |
| EV / EBITDA | 15.09 |
| EV / EBIT | 24.78 |
| EV / FCF | 20.46 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.88.
| Current Ratio | 2.00 |
| Quick Ratio | 1.57 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | 5.74 |
| Debt / FCF | 7.81 |
| Interest Coverage | 2.23 |
Financial Efficiency
Return on equity (ROE) is 4.57% and return on invested capital (ROIC) is 3.08%.
| Return on Equity (ROE) | 4.57% |
| Return on Assets (ROA) | 3.00% |
| Return on Invested Capital (ROIC) | 3.08% |
| Return on Capital Employed (ROCE) | 4.95% |
| Revenue Per Employee | $14.05M |
| Profits Per Employee | $2.53M |
| Employee Count | 50 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SBRA has paid $1.01 million in taxes.
| Income Tax | 1.01M |
| Effective Tax Rate | 0.79% |
Stock Price Statistics
The stock price has increased by +22.53% in the last 52 weeks. The beta is 1.25, so SBRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +22.53% |
| 50-Day Moving Average | 16.76 |
| 200-Day Moving Average | 16.94 |
| Relative Strength Index (RSI) | 53.24 |
| Average Volume (20 Days) | 2,655,354 |
Short Selling Information
The latest short interest is 20.47 million, so 8.60% of the outstanding shares have been sold short.
| Short Interest | 20.47M |
| Short Previous Month | 17.72M |
| Short % of Shares Out | 8.60% |
| Short % of Float | 8.74% |
| Short Ratio (days to cover) | 10.16 |
Income Statement
In the last 12 months, SBRA had revenue of $702.64 million and earned $126.71 million in profits. Earnings per share was $0.54.
| Revenue | 702.64M |
| Gross Profit | 476.12M |
| Operating Income | 256.43M |
| Pretax Income | 54.12M |
| Net Income | 126.71M |
| EBITDA | 421.19M |
| EBIT | 256.43M |
| Earnings Per Share (EPS) | $0.54 |
Full Income StatementBalance Sheet
The company has $81.94 million in cash and $2.43 billion in debt, giving a net cash position of -$2.34 billion or -$9.85 per share.
| Cash & Cash Equivalents | 81.94M |
| Total Debt | 2.43B |
| Net Cash | -2.34B |
| Net Cash Per Share | -$9.85 |
| Equity (Book Value) | 2.74B |
| Book Value Per Share | 11.54 |
| Working Capital | 118.62M |
Full Balance SheetCash Flow
| Operating Cash Flow | 310.54M |
| Capital Expenditures | n/a |
| Free Cash Flow | 310.54M |
| FCF Per Share | $1.31 |
Full Cash Flow StatementMargins
Gross margin is 67.76%, with operating and profit margins of 36.50% and 18.03%.
| Gross Margin | 67.76% |
| Operating Margin | 36.50% |
| Pretax Margin | 18.18% |
| Profit Margin | 18.03% |
| EBITDA Margin | 59.94% |
| EBIT Margin | 36.50% |
| FCF Margin | 44.20% |